BSD SCIENCE is a biotech company that has developed a unique oral dosage form designed for controlled release (CR) of lipophilic drugs, in order to achieve long duration of effect, less adverse effects and higher compliance to treatment. The platform is suitable for lipophilic molecules used in the Medical Cannabis, Pharma industry and Dietary Supplement markets. During 2022, the company completed a POC PK animals study, where promising results were achieved, and U.S. Provisional Patent Application was submitted. BSD SCIENCE plans to move on towards human PK study.